Hyperbaric oxygen therapy may improve symptoms in autistic children

Area of Science:

• Neuroscience
• Developmental Pediatrics

Background:

• Autism spectrum disorder (ASD) is a complex neurodevelopmental condition affecting 1 in 166 children in the US.
• Research indicates autistic individuals may exhibit reduced cerebral blood flow, neuroinflammation, and oxidative stress.
• SPECT and PET scans show hypoperfusion in brain regions crucial for language and auditory processing in autism.

Observation:

• Diminished blood flow in specific brain areas correlates with core autism symptoms.
• These symptoms include communication impairments, social interaction difficulties, and repetitive behaviors.
• Hyperbaric oxygen therapy (HBOT) is a proven treatment for various cerebral hypoperfusion syndromes.

Findings:

• HBOT increases plasma and tissue oxygen levels, potentially compensating for reduced cerebral perfusion.
• Animal studies suggest HBOT possesses anti-inflammatory properties and reduces oxidative stress.
• Emerging evidence indicates HBOT can mobilize stem cells, which may support neurodegenerative recovery.

Implications:

• HBOT is hypothesized to improve autism symptoms by addressing underlying physiological factors.
• A retrospective case series supports the potential efficacy of HBOT for individuals with autism.
• Further research into HBOT as an intervention for autism is warranted.